Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	154
Overall Study	STARTED	2.5 mg Tadalafil	151
Overall Study	STARTED	5.0 mg Tadalafil	155
Overall Study	STARTED	0.2 mg Tamsulosin	152
Overall Study	COMPLETED	Placebo	145
Overall Study	COMPLETED	2.5 mg Tadalafil	136
Overall Study	COMPLETED	5.0 mg Tadalafil	137
Overall Study	COMPLETED	0.2 mg Tamsulosin	143
Overall Study	NOT COMPLETED	Placebo	9
Overall Study	NOT COMPLETED	2.5 mg Tadalafil	15
Overall Study	NOT COMPLETED	5.0 mg Tadalafil	18
Overall Study	NOT COMPLETED	0.2 mg Tamsulosin	9

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00861757/flow